heparin news from FiercePharma
News
Leavitt: We'll bar subs-par exporters
U.S. Health and Human Services honcho Mike Leavitt is baring his teeth at Chinese exporters that don't meet certification standards. Saying that regulators simply can't inspect all imported Read more...
Leavitt: We'll bar subs-par exporters
U.S. Health and Human Services honcho Mike Leavitt is baring his teeth at Chinese exporters that don't meet certification standards. Saying that regulators simply can't inspect all imported Read more...
ALSO NOTED: Pfizer gets new cancer team to advance key drugs; Bayer clearing Trasylol off U.S. market;
> With the clock ticking on its patent for Lipitor, Pfizer has turned to a group of new executives to lead the company to the promised land of new cancer therapies. Read more...
Quaid: Preemption unfair to patients
Dennis Quaid added some star power--and colorful language--to a dry legal debate yesterday. Testifying before Congress, Quaid backed people's right to sue drugmakers, saying that FDA approval Read more...
Preemption debate heats up
That little legal argument known as preemption is back in the news. You know the one: That FDA approval, being federal, supersedes any state-court lawsuits over blessed drugs and devices. Read more...
Politics hampers heparin probes
On the one hand, we have Health and Human Services Secretary Mike Leavitt gladhanding Chinese officials as he announced the heparin supply is now safe--including the crude heparin coming from China's Read more...
SPOTLIGHT: Heparin prices double since recalls
Since Baxter recalled virtually all its heparin products on reports of severe reactions and deaths, the price for the blood thinner has doubled. The sole U.S. supplier, APP Pharmaceuticals, says Read more...
Blaming Baxter, China denies heparin guilt
Point fingers at us, we'll point back at you. That's what China appears to be saying about the heparin scandal, claiming that it wasn't the "heparin-like substance" found in batches of the Read more...
FDA wants power to police imports
The FDA finally put its mouth where the money is. During congressional hearings yesterday, CDER chief Read more...
FDA: Drugmakers responsible for safety
Congress may be all fired up about funding more foreign inspections by the FDA, but the agency itself? Not so much. In Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight